Delivery Order 36F79721D0068-36C24523N0684
Award Date
6/22/23
Potential Completion Date
6/23/23
Potential Value
$97K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Urogen Pharma Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Vergne, TN 37086, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $194,860.32 delivery order to Urogen Pharma Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The firm fixed price order is for the delivery of JELMYTO mitomycin and has an anticipated completion date of August 9, 2023. Placement on the Pharmaceuticals and Drugs FSS vehicle establishes pre-negotiated pricing terms for ordering agencies like the VA to...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed-price delivery order to Urogen Pharma Inc., a for-profit pharmaceutical company, to provide JELMYTO kits. The $98,856.06 order is part of the VA's Pharmaceuticals and Drugs Federal Supply Schedule contract and will be fulfilled by May 10, 2024. Urogen Pharma holds several other VA contract vehicles for JELMYTO, a drug used to treat low-grade upper tract urothelial cancer in veterans, including multiple...
This is a federal contract award by the Department of Veterans Affairs (VA) to Urogen Pharma Inc., a for-profit pharmaceutical company, for the supply of JELMYTO KIT - ANTINEOPLASTIC ANTIBIOTICS. The contract has a ceiling value of $102,264.12 and an ultimate completion date of September 30, 2025. The contract is structured as a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a Firm Fixed Price basis. This contract award is not designated...
<p>Urogen Pharma Inc. was awarded a $97,430.16 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order is for the emergency supply of Jelmyto to the La Vergne, TN facility and has a period of performance through July 6, 2023. No set-aside designation was applied to this award made under GSA Schedule contract FSS-61-IB.</p>
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to UroGen Pharma Inc., a for-profit pharmaceutical company, for the supply of JELMYTO kits. The contract has a ceiling value of $102,264.12 and is valid through September 30, 2025. The contract was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is structured as a firm fixed-price delivery order. No set-aside was used. UroGen Pharma has held multiple indefinite delivery vehicle...
The Department of Veterans Affairs Veterans Health Administration awarded a $24,449.20 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Otsuka America Pharmaceutical Inc. for the drug JYNARQUE. The contract will be performed in Potomac, Maryland from November 22, 2023 through January 22, 2024 to support VHA's Veterans Integrated Service Network 21, which provides healthcare services to veterans in the Mid-Atlantic region. No subcontractors or set aside...
The Department of Veterans Affairs Veterans Health Administration awarded a $12,195.72 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Otsuka America Pharmaceutical Inc. The order is for the drug JYNARQUE 90MG-30MG and has a period of performance from September 19-22, 2023 in Pittsburgh, Pennsylvania. GSA Schedule FSS-61-IB provides federal agencies access to pharmaceutical products and drugs to support the VA's mission of providing quality...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded Ferring Pharmaceuticals Inc. a $45,829.15 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The order is for the delivery of NADOFARAGENE FIRADENOVEC-VNCG SUSP,INTRAVESICAL to locations in Parsippany, New Jersey between December 2023 and April 2024. No subcontractors or set aside designations were identified. This award will provide...
The Department of Veterans Affairs Veterans Health Administration awarded a $48,898.40 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule to Otsuka America Pharmaceutical Inc. for the drug JYNARQUE. The contract has a period of performance from October 20th, 2023 through December 20th, 2023 and will be carried out in Potomac, Maryland. This delivery order was issued under the VA-VHA's Veterans Integrated Service Network 21 to provide JYNARQUE, likely for treatment...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,580.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Otsuka America Pharmaceutical Inc. for the drug JYNARQUE. The firm fixed price order is associated with Master GSA Schedule FSS-61-IB and has a period of performance through March 11, 2024. No subcontractors or set aside designations were identified. The order will support VHA's healthcare...